False Claims Act - G2 Intelligence

Labs in Court: Two EKRA-Related Cases and Some Usual Suspects

Recent enforcement actions involved usual targets such as COVID-19, genetic, and urine drug testing, but EKRA also made an appearance

Start a Free Trial for immediate access to this article

Already a member? Log in here

Recent DOJ settlements continue to focus on issues involving medical necessity and marketer compensation

Start a Free Trial for immediate access to this article

Already a member? Log in here

Lab leaders should be wary of telemedicine arrangements, certain marketing firms, and unnecessary PGx and CGx testing

Start a Free Trial for immediate access to this article

Already a member? Log in here

COVID-19-related schemes dominated recent enforcement efforts, which include a national healthcare fraud enforcement action

Start a Free Trial for immediate access to this article

Already a member? Log in here

Genetic testing related fraud was a theme in recent enforcement actions involving medical laboratories and lab testing

Start a Free Trial for immediate access to this article

Already a member? Log in here